Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.

Use of intravenous immunoglobulin therapy in the treatment of septic shock, in particular severe invasive group A streptococcal disease.

Raithatha AH, Bryden DC.

Indian J Crit Care Med. 2012 Jan;16(1):37-40. doi: 10.4103/0972-5229.94433.

2.

Severe group A streptococcal infection and streptococcal toxic shock syndrome.

Baxter F, McChesney J.

Can J Anaesth. 2000 Nov;47(11):1129-40. Review.

PMID:
11097546
3.

[Invasive streptococcal infections].

Kosina P, Plísek S, Dostál V, Morávková M, Cermák P, Preis J, Lukes A, Kracmarová R, Krausová J.

Klin Mikrobiol Infekc Lek. 2007 Dec;13(6):220-4. Review. Czech.

PMID:
18320500
4.

Intravenous immunoglobulin adjunctive therapy in sepsis, with special emphasis on severe invasive group A streptococcal infections.

Norrby-Teglund A, Ihendyane N, Darenberg J.

Scand J Infect Dis. 2003;35(9):683-9. Review.

PMID:
14620155
5.

Group A Streptococcus invasive infections: a review.

Weiss KA, Laverdière M.

Can J Surg. 1997 Feb;40(1):18-25. Review.

6.

An evaluation of the feasibility, cost and value of information of a multicentre randomised controlled trial of intravenous immunoglobulin for sepsis (severe sepsis and septic shock): incorporating a systematic review, meta-analysis and value of information analysis.

Soares MO, Welton NJ, Harrison DA, Peura P, Shankar- Hari M, Harvey SE, Madan JJ, Ades AE, Palmer SJ, Rowan KM.

Health Technol Assess. 2012;16(7):1-186. doi: 10.3310/hta16070. Review.

7.

Invasive group a streptococcal disease: epidemiology, pathogenesis and management.

Steer AC, Lamagni T, Curtis N, Carapetis JR.

Drugs. 2012 Jun 18;72(9):1213-27. doi: 10.2165/11634180-000000000-00000. Review.

PMID:
22686614
8.

Streptococcal fasciitis with toxic shock syndrome in the pediatric patient.

Jackson MA, Colombo J, Boldrey A.

Orthop Nurs. 2003 Jan-Feb;22(1):4-8. Review.

PMID:
12640946
9.

[Beta-hemolytic streptococcal bacteremia in adults].

Rantala S.

Duodecim. 2013;129(14):1477-84. Review. Finnish.

PMID:
23961606
10.

Intravenous immunoglobulin in critically ill adults: When and what is the evidence?

Wang J, McQuilten ZK, Wood EM, Aubron C.

J Crit Care. 2015 Jun;30(3):652.e9-16. doi: 10.1016/j.jcrc.2015.01.022. Epub 2015 Feb 7. Review.

PMID:
25702845
11.

Invasive group A streptococcus infections.

Stevens DL.

Clin Infect Dis. 1992 Jan;14(1):2-11. Review.

PMID:
1571429
12.
13.

Group B streptococcal necrotizing fasciitis and streptococcal toxic shock-like syndrome in adults.

Gardam MA, Low DE, Saginur R, Miller MA.

Arch Intern Med. 1998 Aug 10-24;158(15):1704-8. Review.

PMID:
9701105
14.
15.

Toxic shock syndrome in children: epidemiology, pathogenesis, and management.

Chuang YY, Huang YC, Lin TY.

Paediatr Drugs. 2005;7(1):11-25. Review.

PMID:
15777108
16.

Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012.

Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, Sevransky JE, Sprung CL, Douglas IS, Jaeschke R, Osborn TM, Nunnally ME, Townsend SR, Reinhart K, Kleinpell RM, Angus DC, Deutschman CS, Machado FR, Rubenfeld GD, Webb SA, Beale RJ, Vincent JL, Moreno R; Surviving Sepsis Campaign Guidelines Committee including the Pediatric Subgroup..

Crit Care Med. 2013 Feb;41(2):580-637. doi: 10.1097/CCM.0b013e31827e83af.

PMID:
23353941
17.

Management of invasive group A streptococcal infections.

Waddington CS, Snelling TL, Carapetis JR.

J Infect. 2014 Nov;69 Suppl 1:S63-9. doi: 10.1016/j.jinf.2014.08.005. Epub 2014 Oct 11. Review.

PMID:
25307276
18.
19.

Invasive group A streptococcal disease.

Stevens DL.

Infect Agents Dis. 1996 Jun;5(3):157-66. Review.

PMID:
8805078
20.

The flesh-eating bacterium: what's next?

Stevens DL.

J Infect Dis. 1999 Mar;179 Suppl 2:S366-74. Review.

PMID:
10081509

Supplemental Content

Support Center